MedTrace Logo

Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

NCT04516395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-08-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the treatment outcomes in patients with CRE infections.

Conditions

  • Drug Resistance
  • Carbapenem-Resistant Enterobacteriaceae Infection
  • Sepsis
  • Septic Shock
  • Critical Illness
  • Clinical Outcomes
  • Treatment Outcomes

Interventions

OTHER

Combined antibiotic regimens

Combined antibiotic combinations defined as the optimal antibiotic combination regimens which are created from in vitro study and the application of PK/PD.

OTHER

Standard antibiotic regimens

Standard antibiotic regimens defined as the antibiotic regimens which are generally given to the patients following to the hospital protocol.

Sponsors & Collaborators

  • Phramongkutklao College of Medicine and Hospital

    lead OTHER

Principal Investigators

  • Wichai Santimaleeworagun · Silpakorn University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2021-03-31
Completion
2021-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04516395 on ClinicalTrials.gov